NO991869L - Ultralydkontrastmiddel - Google Patents

Ultralydkontrastmiddel

Info

Publication number
NO991869L
NO991869L NO991869A NO991869A NO991869L NO 991869 L NO991869 L NO 991869L NO 991869 A NO991869 A NO 991869A NO 991869 A NO991869 A NO 991869A NO 991869 L NO991869 L NO 991869L
Authority
NO
Norway
Prior art keywords
contrast agent
ultrasound contrast
ultrasound
agent
contrast
Prior art date
Application number
NO991869A
Other languages
English (en)
Other versions
NO991869D0 (no
Inventor
Jonny Ostensen
Morten Eriksen
Sigmund Frigstad
Pol Rongved
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9621884.7A external-priority patent/GB9621884D0/en
Priority claimed from GBGB9708239.0A external-priority patent/GB9708239D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO991869D0 publication Critical patent/NO991869D0/no
Publication of NO991869L publication Critical patent/NO991869L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927Diagnostic contrast agent
    • Y10S977/928X-ray agent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927Diagnostic contrast agent
    • Y10S977/929Ultrasound contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO991869A 1996-10-21 1999-04-19 Ultralydkontrastmiddel NO991869L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9621884.7A GB9621884D0 (en) 1996-10-21 1996-10-21 Improvements in or relating to contrast agents
GBGB9708239.0A GB9708239D0 (en) 1997-04-23 1997-04-23 Improvements in or relating to contrast agents
PCT/GB1997/002898 WO1998017324A2 (en) 1996-10-21 1997-10-21 Improvements in or relating to contrast agents

Publications (2)

Publication Number Publication Date
NO991869D0 NO991869D0 (no) 1999-04-19
NO991869L true NO991869L (no) 1999-06-02

Family

ID=26310262

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991869A NO991869L (no) 1996-10-21 1999-04-19 Ultralydkontrastmiddel

Country Status (26)

Country Link
US (3) US6375931B2 (no)
EP (2) EP1264604B1 (no)
JP (1) JP2001502349A (no)
KR (1) KR20000052652A (no)
CN (1) CN1106859C (no)
AP (1) AP885A (no)
AT (2) ATE238073T1 (no)
AU (1) AU745047B2 (no)
BG (1) BG103402A (no)
BR (1) BR9712370A (no)
CA (1) CA2269319C (no)
CZ (1) CZ140999A3 (no)
DE (2) DE69738406T2 (no)
EE (1) EE03749B1 (no)
ES (1) ES2197336T3 (no)
HU (1) HU224218B1 (no)
ID (1) ID21681A (no)
IL (1) IL129423A (no)
MX (1) MXPA99003664A (no)
NO (1) NO991869L (no)
NZ (1) NZ335265A (no)
PL (1) PL332820A1 (no)
RU (1) RU2204415C2 (no)
SK (1) SK283210B6 (no)
TR (1) TR199901544T2 (no)
WO (1) WO1998017324A2 (no)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
CA2248158A1 (en) * 1996-03-12 1997-09-18 The Board Of Regents Of The University Of Nebraska Targeted site specific drug delivery compositions and method of use
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
JP4139440B2 (ja) * 1996-09-11 2008-08-27 イマアーレクス・フアーマシユーチカル・コーポレーシヨン 造影剤及び血管拡張薬を用いる画像診断のための改良された方法
EP1264604B1 (en) * 1996-10-21 2007-12-19 GE Healthcare AS Improvements in or relating to contrast agents
GB9708246D0 (en) 1997-04-24 1997-06-18 Nycomed Imaging As Improvements in or relating to ultrasound imaging
GB9717588D0 (en) 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
EP1024837A1 (en) * 1997-10-21 2000-08-09 Nycomed Imaging As Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19805012A1 (de) * 1998-02-07 1999-08-12 Thomas Gieselmann Kontrastmittel zur Verwendung als Diagnostikum bei bildgebenden Verfahren sowie seine Herstellung
GB9808581D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
GB9808599D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or realting to contrast agents
GB9808582D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
US20040170564A1 (en) * 1998-04-22 2004-09-02 Roald Skurtveit Ultrasound contrast agent dispersions comprising gas and destabilising agent
GB9813568D0 (en) * 1998-06-23 1998-08-19 Nycomed Imaging As Improvements in or relating to cardiac imaging
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
NO20010234D0 (no) * 2001-01-12 2001-01-12 Nycomed Imaging As Perfusjon avbildningsbilde
US7179449B2 (en) * 2001-01-30 2007-02-20 Barnes-Jewish Hospital Enhanced ultrasound detection with temperature-dependent contrast agents
DE10115740A1 (de) * 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
US20040166152A1 (en) * 2002-02-14 2004-08-26 Andreas Hirsch Use of buckysome or carbon nanotube for drug delivery
US20080193490A1 (en) * 2002-02-14 2008-08-14 Andreas Hirsch Use of Carbon Nanotube for Drug Delivery
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
CA2477836A1 (en) 2002-03-01 2003-09-12 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US20050100963A1 (en) 2002-03-01 2005-05-12 Dyax Corporation KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US20090060992A1 (en) * 2002-05-08 2009-03-05 University Of Central Florida Research Foundation, Inc., Preparation of magneto-vesicles with DOPE/DDAB layers
AU2003247376A1 (en) * 2002-05-17 2003-12-02 Case Western Reserve University Double contrast technique for mri-guided vascular interventions
US7767232B2 (en) * 2002-09-19 2010-08-03 New York University Control of nitric oxide bioactivity by perfluorocarbons
DE10244847A1 (de) * 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
DK1593091T3 (da) * 2003-01-25 2013-10-28 Seno Medical Instr Inc Optoakustisk afbildning med høj kontrast ved anvendelse af ikke-sfæriske nanopartikler
US20040146461A1 (en) * 2003-01-29 2004-07-29 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7378081B2 (en) 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
CN1744906B (zh) * 2003-01-31 2010-08-18 株式会社大塚制药工厂 利用介电加热的癌症治疗方法中所使用的辅助剂以及癌症治疗方法
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
KR101076053B1 (ko) * 2003-02-04 2011-10-21 브라코 인터내셔날 비.브이. 초음파 조영제 및 그것의 제조방법
US20050214859A1 (en) 2003-03-03 2005-09-29 Dyax Corp. Peptides that specifically bind HGF receptor (cMet) and uses thereof
US20040258760A1 (en) * 2003-03-20 2004-12-23 Wheatley Margaret A. Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
US20080299047A1 (en) * 2003-07-31 2008-12-04 National Cheng Kung University Method for preparation of water-soluble and dispersed iron oxide nanoparticles and application thereof
SE526838C2 (sv) * 2003-11-27 2005-11-08 Xcounter Ab Undersökningsmetod och anordning för detektion av joniserande strålning
US9750821B2 (en) * 2003-12-22 2017-09-05 Bracco Suisse S.A. Gas-filled microvesicle assembly for contrast imaging
EP1750668B1 (en) * 2004-04-13 2010-02-17 Nova Bio-Pharma Technologies Limited Liquids containing suspended glass particles
US8012457B2 (en) * 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
CN101005858A (zh) * 2004-08-18 2007-07-25 伯拉考开发股份有限公司 用于反差成像的充气微泡组合物
US8034222B2 (en) * 2004-10-26 2011-10-11 The Regents Of The University Of California Conducting polymer nanowire sensors
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
US20070167864A1 (en) * 2005-11-29 2007-07-19 Lopez George A Cardiac output measurement devices and methods
EP2359864B1 (en) 2005-12-09 2019-04-17 Bracco Suisse SA Targeting Vector-Phospholipid Conjugates
KR20080114758A (ko) * 2006-02-28 2008-12-31 이 아이 듀폰 디 네모아 앤드 캄파니 세정 분야를 위한 플루오르화 화합물을 포함하는 공비 조성물
CN100400105C (zh) * 2006-05-11 2008-07-09 上海交通大学 水性基质的消化道ct阴性造影剂及其制备方法
JP4279328B2 (ja) * 2007-05-07 2009-06-17 株式会社日立製作所 超音波撮像システム
KR100957560B1 (ko) * 2007-10-18 2010-05-11 한국생명공학연구원 양자점 나노입자를 함유한 퍼플루오르카본 나노에멀젼 및그 제조방법
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
EP2335171A2 (en) * 2008-09-30 2011-06-22 Koninklijke Philips Electronics N.V. Perfusion imaging
US9072490B2 (en) * 2010-12-20 2015-07-07 Toshiba Medical Systems Corporation Image processing apparatus and image processing method
ITRM20110022A1 (it) * 2011-01-21 2012-07-22 Gaio Paradossi Metodo per la preparazione di microbolle comprendenti un agente di contrasto
RU2454174C2 (ru) * 2011-03-16 2012-06-27 Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Способ диагностики опухолей шейки матки
RU2453270C1 (ru) * 2011-03-31 2012-06-20 Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена Министерства здравоохранения и социального развития Российской Федерации" (ФГУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Способ исследования терминального отдела толстой кишки
RU2485976C2 (ru) * 2011-05-17 2013-06-27 Государственное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО СибГМУ Минздравсоцразвития России) Контрастное средство для ультразвуковой визуализации
CN104349827A (zh) * 2012-04-30 2015-02-11 通用电气医疗集团股份有限公司 向容器中灌装发泡组合物的方法
JP6420761B2 (ja) * 2012-06-26 2018-11-07 ジーイー・ヘルスケア・アクスイェ・セルスカプ 気体マイクロバブルを含む組成物の調製
CN103100093B (zh) * 2013-01-23 2015-05-06 中山大学附属第三医院 一种负载小干扰rna的纳米级脂质微泡超声造影剂及制备方法
RS63646B1 (sr) * 2013-09-27 2022-11-30 Exact Therapeutics As Isporuka lekova posredovana ultrazvukom
CN113289034A (zh) 2014-12-31 2021-08-24 蓝瑟斯医学影像公司 脂质封装的气体微球组合物及相关方法
BR112018072342A2 (pt) 2016-05-04 2019-02-19 Lantheus Medical Imaging, Inc. métodos e dispositivos para preparação de agentes de contraste de ultrassom
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof
US11642172B2 (en) * 2019-03-05 2023-05-09 Biosense Webster (Israel) Ltd. Showing catheter in brain
US12005130B2 (en) 2019-10-16 2024-06-11 Agitated Solutions Inc. Generating microbubbles for bubble studies
US11191888B1 (en) 2020-05-18 2021-12-07 Agitated Solutions Inc. Syringe-based microbubble generator
RU2744825C1 (ru) * 2020-06-03 2021-03-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Смоленский государственный медицинский университет" министерства здравоохранения Российской Федерации Способ определения времени течения артериальной фазы эхоконтрастирования печени, почек и селезенки

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5117830A (en) * 1990-11-08 1992-06-02 Whitby Research, Inc. Method of determining viability of tissue
CA2154590C (en) * 1993-01-25 2001-06-12 Steven C. Quay Phase shift colloids as ultrasound contrast agents
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
US5605673A (en) * 1993-07-30 1997-02-25 Alliance Pharmaceutical Corp. Stabilized microbubble compositions for ultrasound
US5798091A (en) * 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
DE4406474A1 (de) * 1994-02-23 1995-08-24 Schering Ag Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5560364A (en) * 1995-05-12 1996-10-01 The Board Of Regents Of The University Of Nebraska Suspended ultra-sound induced microbubble cavitation imaging
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
EP1264604B1 (en) * 1996-10-21 2007-12-19 GE Healthcare AS Improvements in or relating to contrast agents
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles

Also Published As

Publication number Publication date
DE69738406D1 (de) 2008-01-31
DE69721331D1 (de) 2003-05-28
CN1106859C (zh) 2003-04-30
AU745047B2 (en) 2002-03-07
KR20000052652A (ko) 2000-08-25
ID21681A (id) 1999-07-08
AP885A (en) 2000-11-03
DE69721331T2 (de) 2004-05-06
US20050118104A1 (en) 2005-06-02
SK283210B6 (sk) 2003-03-04
BR9712370A (pt) 1999-08-31
WO1998017324A2 (en) 1998-04-30
IL129423A0 (en) 2000-02-17
EP1007100A2 (en) 2000-06-14
DE69738406T2 (de) 2008-12-04
ATE381353T1 (de) 2008-01-15
EP1007100B1 (en) 2003-04-23
SK52099A3 (en) 2000-01-18
ES2197336T3 (es) 2004-01-01
HUP0000282A3 (en) 2001-09-28
MXPA99003664A (es) 2002-06-11
HUP0000282A2 (hu) 2000-05-28
US20010002993A1 (en) 2001-06-07
CZ140999A3 (cs) 1999-09-15
CN1238699A (zh) 1999-12-15
AU4714797A (en) 1998-05-15
AP9901511A0 (en) 1999-06-30
TR199901544T2 (xx) 1999-09-21
EP1264604B1 (en) 2007-12-19
RU2204415C2 (ru) 2003-05-20
IL129423A (en) 2003-01-12
EE03749B1 (et) 2002-06-17
NZ335265A (en) 2000-07-28
EE9900158A (et) 1999-12-15
US20040141921A1 (en) 2004-07-22
BG103402A (bg) 2000-01-31
ATE238073T1 (de) 2003-05-15
EP1264604A2 (en) 2002-12-11
CA2269319C (en) 2008-03-18
JP2001502349A (ja) 2001-02-20
PL332820A1 (en) 1999-10-11
CA2269319A1 (en) 1998-04-30
HU224218B1 (hu) 2005-06-28
US6783752B2 (en) 2004-08-31
WO1998017324A3 (en) 1998-06-25
NO991869D0 (no) 1999-04-19
EP1264604A3 (en) 2004-03-10
US6375931B2 (en) 2002-04-23

Similar Documents

Publication Publication Date Title
NO991869L (no) Ultralydkontrastmiddel
NO971041D0 (no) Brönn-frakoplingsverktöy
DE69517659D1 (de) Verbinder
NO985294D0 (no) Kontrastmidler
DE69534990D1 (de) Kontrastmittel
DE69513300D1 (de) Bestimmungsverfahren
IS4399A (is) Tafefni gegn interlevkín-1ß umbreytiensími
DE69902928D1 (de) Ultraschallsverbindungsverfahren
DE69808397D1 (de) Ultraschallvorrichtung
DE69534561D1 (de) Sender-empfänger
DE69521660D1 (de) Verbinder
FI955503A0 (fi) Liitoslaite
DE69830139D1 (de) Ultraschall lockenwickelgerät
DE69714574D1 (de) Universal-nietwerkzeug
DE59711146D1 (de) Cpkd-karosserie
DE69806069D1 (de) Ultraschall-hornstrahler
DE59809001D1 (de) Ultraschallsensor
DE69933833D1 (de) Ultraschall-Diagnosesystem
NO993438D0 (no) Kontrastmidler for ultralyd
NO992737D0 (no) Formslippmiddel
FI943329A (fi) Liitosjärjestely
DE69709700D1 (de) Kontrastmittel
NO983420D0 (no) Ultralydkontrastmiddel
DE59711179D1 (de) Ultraschallwandler
NO991735D0 (no) Vaskemiddelblanding

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application